{"organizations": [], "uuid": "744e8332fabe65d0843dbc661e882d8ea68726d5", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-antares-pharma-provides-xyosted-re/brief-antares-pharma-provides-xyosted-regulatory-update-idUSASB0C0ZK", "country": "US", "domain_rank": 408, "title": "BRIEF-Antares Pharma Provides Xyosted Regulatory Update", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-16T14:49:00.000+02:00", "replies_count": 0, "uuid": "744e8332fabe65d0843dbc661e882d8ea68726d5"}, "author": "", "url": "https://www.reuters.com/article/brief-antares-pharma-provides-xyosted-re/brief-antares-pharma-provides-xyosted-regulatory-update-idUSASB0C0ZK", "ord_in_thread": 0, "title": "BRIEF-Antares Pharma Provides Xyosted Regulatory Update", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "brief-antares pharma provides xyosted regulatory update", "sentiment": "negative"}, {"name": "brief-antares pharma provides xyosted regulatory update reuters", "sentiment": "negative"}, {"name": "antares pharma", "sentiment": "none"}, {"name": "antares pharma inc", "sentiment": "none"}, {"name": "antares pharma inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "antares", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 50 PM / Updated 9 minutes ago BRIEF-Antares Pharma Provides Xyosted Regulatory Update Reuters Staff \nJan 16 (Reuters) - Antares Pharma Inc: * ANTARES PHARMA PROVIDES XYOSTEDâ„¢ REGULATORY UPDATE \n* ANTARES PHARMA INC - TYPE A MEETING HAS BEEN SCHEDULED WITH U.S. FOOD AND DRUG ADMINISTRATION ON FEBRUARY 21, 2018 FOR XYOSTED \n* ANTARES PHARMA - REQUEST FOR MEETING WAS IN RESPONSE TO COMPLETE RESPONSE LETTER RECEIVED BY ANTARES REGARDING NEW DRUG APPLICATION FOR XYOSTED Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-16T14:49:00.000+02:00", "crawled": "2018-01-16T15:02:29.013+02:00", "highlightTitle": ""}